Bio-Path Holdings Presents Data from Ongoing Phase 2 Study of Prexigebersen at 2021 American Society of Hematology Annual Meeting
Bio-Path Holdings to Present Clinical Data at the 63rd Annual American Society of Hematology Annual Meeting